µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© SAnr|<Y/
)#AYb
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© %ZoJu
1¡¢Co-stimulators (or co-stimulating molecules) w}1IP-
2¡¢NK-kB b_Y+XXb<
3¡¢Immunoglobulin superfamily # m|el@)
4¡¢antigen-presenting cell (APC) M
zg'$]N
5¡¢death domain #N`'hPD}
6¡¢CCR and CXCR 1tXc7NA<
7¡¢Lectin (or mitogen) :
fmV||Q
8¡¢Clusters of differentiation, CD) N,w6
9¡¢B7 family #xmiUN,|
10¡¢Cytotoxic T lymphocyte, CTL) ^RnQX#+
11¡¢IL-15 and IL-15 receptor (IL-15R) )%jS9e{d
12¡¢MHC restriction u|23M,
13¡¢Affinity-chromatography V.3#O^S
14¡¢Cyctosprin A, CsA }|h-=T '
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) @dQ
r^'h
(NUXK
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© =O8 YU)#
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 {$ N\@q@v~
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ *Iw19o-I
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ W=2.0QmW
|QzJHP @
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© zX=%BL?
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ :x q^T
ѪҺ²¡Ñ§×¨Òµ£º pnz@;+f
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿